| Literature DB >> 36061974 |
Orgest Lajthia1, Mithun G Sattur1, Abhay K Varma1.
Abstract
BACKGROUND: Dural reconstruction to achieve expansion duraplasty is important in suboccipital decompression for Chiari malformation type 1 (CM1). Although various dural substitutes are available, including synthetic collagen matrix grafts and dural xenografts, they have the potential to induce an inflammatory response. In this case series, the authors present their experience and discuss the incidence and possible mechanism of aseptic meningitis after the use of bovine collagen matrix graft as a dural substitute in patients with CM1 after suboccipital decompression. OBSERVATIONS: Three consecutive adult female patients who underwent suboccipital decompression at a single institution by a single neurosurgeon were retrospectively reviewed. They all presented with signs of aseptic meningitis in a delayed fashion, responded well to steroid administration, but had recurrence of their symptoms. Bovine collagen dural substitutes are resorbed in a process that induces an inflammatory response manifesting with signs of aseptic meningitis and is only alleviated with removal of the dural substitute. LESSONS: DuraMatrix Suturable, a dural xenograft derived from bovine dermis, though a viable choice for dural repair, is a potential cause of chemical meningitis after duraplasty in Chiari decompression surgery. In patients presenting with delayed and persistent aseptic meningitis after intervention, removal of this dural substitute led to improved symptomatology.Entities:
Keywords: CM1 = Chiari malformation type 1; CSF = cerebrospinal fluid; Chiari malformation; MRI = magnetic resonance imaging; aseptic meningitis; chemical meningitis; dural grafts; duraplasty; suboccipital decompression
Year: 2021 PMID: 36061974 PMCID: PMC9435574 DOI: 10.3171/CASE21331
Source DB: PubMed Journal: J Neurosurg Case Lessons ISSN: 2694-1902
Surgical characteristics
| Variable | Case 1 | Case 2 | Case 3 |
|---|---|---|---|
| Dural graft | Suturable DuraMatrix | Suturable DuraMatrix | Suturable DuraMatrix |
| Dural sutures | 6-0 Prolene | 6-0 Prolene | 5-0 Prolene |
| Tisseel | Yes | Yes | Yes |
| Length of stay, days | 5 | 9 | 4 |
| Revision surgery, days | 51 | 51 | 35 |
| Dural graft | Periosteal graft | Onlay DuraMatrix | Onlay DuraMatrix |
| Dural sutures | 6-0 Prolene | None | None |
| Shunt | Lumboperitoneal | VPS | None |
VPS = ventriculoperitoneal shunt.
CSF findings
| Variable | Case 1 | Case 2 | Case 3 |
|---|---|---|---|
| Red blood cells, mm3 | 150 | 83 | 207 |
| White blood cells, mm3 | 215 | 11 | 605 |
| Glucose, mg/dl | 49 | 43 | 58 |
| Protein, mg/dl | 53 | 180 | 138 |
| Nucleated cells, mm3 | 250 | 12 | 703 |
| Neutrophils, % | 3 | 6 | 1 |
| Lymphocytes, % | 78 | 85 | 35 |
| Eosinophils, % | 5 | 0 | 50 |
| Monocytes/macrophages, % | 14 | 9 | 14 |
| Culture | Negative | Negative | Negative |